Literature DB >> 24838580

Increased oxidative stress and impaired antioxidant response in Lafora disease.

Carlos Romá-Mateo1, Carmen Aguado, José Luis García-Giménez, José Santiago Ibáñez-Cabellos, Marta Seco-Cervera, Federico V Pallardó, Erwin Knecht, Pascual Sanz.   

Abstract

Lafora disease (LD, OMIM 254780, ORPHA501) is a fatal neurodegenerative disorder characterized by the presence of glycogen-like intracellular inclusions called Lafora bodies and caused, in the vast majority of cases, by mutations in either EPM2A or EPM2B genes, encoding respectively laforin and malin. In the last years, several reports have revealed molecular details of these two proteins and have identified several processes affected in LD, but the pathophysiology of the disease still remains largely unknown. Since autophagy impairment has been reported as a characteristic treat in both Lafora disease cell and animal models, and as there is a link between autophagy and mitochondrial performance, we sought to determine if mitochondrial function could be altered in those models. Using fibroblasts from LD patients, deficient in laforin or malin, we found mitochondrial alterations, oxidative stress and a deficiency in antioxidant enzymes involved in the detoxification of reactive oxygen species (ROS). Similar results were obtained in brain tissue samples from transgenic mice deficient in either the EPM2A or EPM2B genes. Furthermore, in a proteomic analysis of brain tissue obtained from Epm2b-/- mice, we observed an increase in a modified form of peroxiredoxin-6, an antioxidant enzyme involved in other neurological pathologies, thus corroborating an alteration of the redox condition. These data support that oxidative stress produced by an increase in ROS production and an impairment of the antioxidant enzyme response to this stress play an important role in development of LD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24838580     DOI: 10.1007/s12035-014-8747-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  47 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  OLAV: towards high-throughput tandem mass spectrometry data identification.

Authors:  Jacques Colinge; Alexandre Masselot; Marc Giron; Thierry Dessingy; Jérôme Magnin
Journal:  Proteomics       Date:  2003-08       Impact factor: 3.984

Review 3.  Oxidative stress and autophagy.

Authors:  Roberta Kiffin; Urmi Bandyopadhyay; Ana Maria Cuervo
Journal:  Antioxid Redox Signal       Date:  2006 Jan-Feb       Impact factor: 8.401

Review 4.  Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A₂ activities.

Authors:  Aron B Fisher
Journal:  Antioxid Redox Signal       Date:  2011-03-31       Impact factor: 8.401

Review 5.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.

Authors:  Michael T Lin; M Flint Beal
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

6.  Sequestration of chaperones and proteasome into Lafora bodies and proteasomal dysfunction induced by Lafora disease-associated mutations of malin.

Authors:  Sudheendra N R Rao; Ranjan Maity; Jaiprakash Sharma; Parthanarayan Dey; Susarla Krishna Shankar; Parthasarathy Satishchandra; Nihar Ranjan Jana
Journal:  Hum Mol Genet       Date:  2010-09-21       Impact factor: 6.150

7.  Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.

Authors:  Maria Carmen Solaz-Fuster; José Vicente Gimeno-Alcañiz; Susana Ros; Maria Elena Fernandez-Sanchez; Belen Garcia-Fojeda; Olga Criado Garcia; David Vilchez; Jorge Dominguez; Mar Garcia-Rocha; Maribel Sanchez-Piris; Carmen Aguado; Erwin Knecht; Jose Serratosa; Joan Josep Guinovart; Pascual Sanz; Santiago Rodriguez de Córdoba
Journal:  Hum Mol Genet       Date:  2007-11-20       Impact factor: 6.150

Review 8.  Mitochondrial involvement in temporal lobe epilepsy.

Authors:  Alexei P Kudin; Gábor Zsurka; Christian E Elger; Wolfram S Kunz
Journal:  Exp Neurol       Date:  2009-03-05       Impact factor: 5.330

9.  The malin-laforin complex suppresses the cellular toxicity of misfolded proteins by promoting their degradation through the ubiquitin-proteasome system.

Authors:  Punitee Garyali; Pratibha Siwach; Pankaj Kumar Singh; Rajat Puri; Shuchi Mittal; Sonali Sengupta; Rashmi Parihar; Subramaniam Ganesh
Journal:  Hum Mol Genet       Date:  2008-11-25       Impact factor: 6.150

Review 10.  Oxidative stress and epilepsy: literature review.

Authors:  Carlos Clayton Torres Aguiar; Anália Barbosa Almeida; Paulo Victor Pontes Araújo; Rita Neuma Dantas Cavalcante de Abreu; Edna Maria Camelo Chaves; Otoni Cardoso do Vale; Danielle Silveira Macêdo; David John Woods; Marta Maria de França Fonteles; Silvania Maria Mendes Vasconcelos
Journal:  Oxid Med Cell Longev       Date:  2012-07-14       Impact factor: 6.543

View more
  18 in total

Review 1.  [Lafora disease: a review of the literature].

Authors:  L Desdentado; R Espert; P Sanz; J Tirapu-Ustarroz
Journal:  Rev Neurol       Date:  2019-01-16       Impact factor: 0.870

2.  Sodium selenate treatment improves symptoms and seizure susceptibility in a malin-deficient mouse model of Lafora disease.

Authors:  Gentzane Sánchez-Elexpuru; José M Serratosa; Marina P Sánchez
Journal:  Epilepsia       Date:  2017-01-18       Impact factor: 5.864

Review 3.  Lafora disease: from genotype to phenotype.

Authors:  Rashmi Parihar; Anupama Rai; Subramaniam Ganesh
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

4.  4-Phenylbutyric acid and metformin decrease sensitivity to pentylenetetrazol-induced seizures in a malin knockout model of Lafora disease.

Authors:  Gentzane Sánchez-Elexpuru; José M Serratosa; Pascual Sanz; Marina P Sánchez
Journal:  Neuroreport       Date:  2017-03-22       Impact factor: 1.837

5.  Homeostasis of the astrocytic glutamate transporter GLT-1 is altered in mouse models of Lafora disease.

Authors:  Carmen Muñoz-Ballester; Arnaud Berthier; Rosa Viana; Pascual Sanz
Journal:  Biochim Biophys Acta       Date:  2016-03-11

6.  Trehalose Ameliorates Seizure Susceptibility in Lafora Disease Mouse Models by Suppressing Neuroinflammation and Endoplasmic Reticulum Stress.

Authors:  Priyanka Sinha; Bhupender Verma; Subramaniam Ganesh
Journal:  Mol Neurobiol       Date:  2020-10-22       Impact factor: 5.590

7.  Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease.

Authors:  Pablo Sanchez-Martin; Marcos Lahuerta; Rosa Viana; Erwin Knecht; Pascual Sanz
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-11-21       Impact factor: 4.739

8.  A novel EPM2A mutation yields a slow progression form of Lafora disease.

Authors:  Maria Adelaida Garcia-Gimeno; Pilar Natalia Rodilla-Ramirez; Rosa Viana; Xavier Salas-Puig; M Kathryn Brewer; Matthew S Gentry; Pascual Sanz
Journal:  Epilepsy Res       Date:  2018-07-21       Impact factor: 3.045

9.  Degradation of altered mitochondria by autophagy is impaired in Lafora disease.

Authors:  Marcos Lahuerta; Carmen Aguado; Pablo Sánchez-Martín; Pascual Sanz; Erwin Knecht
Journal:  FEBS J       Date:  2018-04-23       Impact factor: 5.542

10.  Inflammation in Lafora Disease: Evolution with Disease Progression in Laforin and Malin Knock-out Mouse Models.

Authors:  Irene López-González; Rosa Viana; Pascual Sanz; Isidre Ferrer
Journal:  Mol Neurobiol       Date:  2016-04-04       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.